Shozo Furumoto
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Journal: EJNMMI radiopharmacy and chemistry
Published: February 25, 2026
In-depth multimodal validation of 18F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer's and related neurodegenerative diseases.
Journal: Experimental & molecular medicine
Published: January 06, 2026
Automated cassette-based synthesis, metabolism, and dosimetry of [18F]ApaScan, a PET tracer for aldosterone synthase imaging.
Journal: Nuclear medicine and biology
Published: December 06, 2025
Astrocyte reactivity across the AD continuum measured by [18F]SMBT-1 and its relationship with the Aβ burden.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 16, 2025
Automated radiosynthesis and clinical experience of [18F]SMBT-1 PET imaging for in vivo evaluation of reactive astrocyte in Parkinson's disease: a pilot study.
Journal: Frontiers in nuclear medicine
Published: October 03, 2025
Whole-body biodistribution of [18F]SMBT-1: a novel PET tracer for monoamine oxidase B imaging in healthy humans.
Journal: Annals of nuclear medicine
Published: August 22, 2025
Production of 64Cu and 67Cu with accelerator neutrons by deuterons and their separation from zinc.
Journal: Frontiers in nuclear medicine
Published: June 30, 2025
Visualization of Apolipoprotein E-Binding Amyloid Plaques in Postmortem Alzheimer's Disease Brains Using a Novel Fluorescent Probe THK-5320.
Journal: ACS chemical neuroscience
Published: April 28, 2025
Kinetic and quantitative analysis of [18F]SMBT-1 PET imaging for monoamine oxidase B.
Journal: Annals of nuclear medicine
Published: April 03, 2025
Current Progress and Future Directions in Non-Alzheimer's Disease Tau PET Tracers.
Journal: ACS chemical neuroscience
Published: January 06, 2025
Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus.
Journal: Nuclear medicine and biology
Published: October 15, 2024
Last Updated: 09/26/2026